SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

TLX.L (TLX.L) News

Track canonical SquawkNews coverage tagged to TLX.L, TLX.L. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol TLX.L Asset market Sector Markets 90 days 1 Updated Jul 07, 2026, 04:51 PM UTC Open live news feed
H Telix Pharmaceuticals price target lowered to $22 from $22.50 at Citi Citi lowered the firm's price target on Telix Pharmaceuticals to $22 from $22.50 and keeps a Buy rating on the shares. Q2 Visible Alpha consensus of $184M in Illuccix/Gozellix sales "looks reasonable," says the analyst, EQUITY | Jul 07, 2026, 04:51 PM UTC